TY - JOUR T1 - Glib aside: sulphonylureas in advanced kidney disease JF - BMJ Evidence-Based Medicine JO - BMJ EBM DO - 10.1136/bmjebm-2020-111465 SP - bmjebm-2020-111465 AU - James Shand AU - Kate Bradley Y1 - 2020/08/10 UR - http://ebm.bmj.com/content/early/2020/08/10/bmjebm-2020-111465.abstract N2 - Recent, BMJ Evidence Based Medicine (EBM) articles have highlighted a number of concerns pertaining to academic validity in medical guidelines. In the September 2019 issue, Braithwaite1 decried a ‘startling disconnect’ between EBM theory and the processes by which academic authorities accumulate and communicate evidence. Meanwhile, in the February 2020 issue, Bareket et al2 noted the often inadvertent accumulation of error through authors ‘citing non-primary data and amplifying the errors of their predecessors’. Taken together, these procedural errors erode the academic backbone of medical guidelines and are thereby threaten the real-world foundation of evidence-based practice.3 However, these factors may be overlooked by the busy clinician, … ER -